Diabetes Devices Market Set to Reach US$70.6 Billion by 2035, Driven by Smart Monitoring and Advanced Insulin Delivery Technologies

The global diabetes devices market is evolving rapidly as diabetes prevalence rises and patients increasingly seek convenient, accurate, and personalized disease-management solutions. The market was valued at US$32.4 billion in 2024 and is expected to reach US$70.6 billion by 2035, advancing at a 7.4% CAGR during 2025–2035.

👉 Get sample market research report copy now@ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=14

Diabetes devices include glucose monitoring systems, insulin delivery products, diabetes management software, and automated treatment technologies. Continuous glucose monitoring (CGM), insulin pumps, smart insulin pens, blood glucose meters, and connected mobile applications are becoming increasingly important in day-to-day diabetes management.

Market Overview

The diabetes devices industry is being shaped by two major developments: the growing global diabetes population and the transition toward technology-enabled chronic disease management.

Glucose monitoring devices represent a critical part of the market, ranging from traditional blood glucose meters and testing strips to advanced CGM sensors, transmitters, and receivers. At the same time, insulin delivery devices—including syringes, pens, pumps, and jet injectors—are gaining technological capabilities designed to improve dosing convenience and treatment adherence.

Integration with smartphones, cloud platforms, telehealth services, and digital health applications is creating a connected diabetes-care ecosystem. These technologies allow real-time information sharing between patients, caregivers, and healthcare professionals.

Key Drivers of Market Growth

Rising Global Prevalence of Diabetes

The expanding diabetes population remains one of the strongest growth factors for diabetes devices. Sedentary lifestyles, urbanization, changing dietary patterns, obesity, and population aging are increasing the need for long-term glucose monitoring and insulin management.

As awareness of diabetes management improves, patients and healthcare providers are increasingly adopting technologies that provide continuous and actionable information. CGM systems, insulin pumps, and smart insulin pens can support more informed treatment decisions and personalized care.

Growing Demand for Home Healthcare and Self-Management

Healthcare is increasingly moving beyond hospitals and clinics. Patients want solutions that allow them to monitor glucose, administer insulin, and manage their condition at home.

This trend is strengthening demand for compact, wearable, connected, and easy-to-operate devices. Remote monitoring and telehealth capabilities further support this shift by allowing clinicians to review patient data without requiring frequent in-person visits.

Key Players and Industry Leaders

The competitive landscape includes established medical-device manufacturers, pharmaceutical companies, and specialized diabetes-technology providers. Major companies include Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc., SOOIL Developments Co., Ltd., F. Hoffmann-La Roche AG, Ypsomed, Terumo Corporation, MicroTech Medical, Jiangsu Delfu, Medtrum Technologies, Novo Nordisk, Sanofi, and Abbott.

Key Trends for the Future

One of the most significant trends is the convergence of diabetes devices with digital health. Mobile applications and cloud-based platforms are enabling continuous data exchange and personalized insights.

Another important trend is the development of automated insulin delivery and artificial pancreas systems. These technologies aim to reduce the daily burden associated with diabetes management by connecting glucose monitoring with insulin delivery.

Wearable technologies, smaller sensors, longer-lasting devices, simplified insertion systems, and improved smartphone compatibility are also expected to influence product development.

Explore our report to uncover in-depth insights - https://www.transparencymarketresearch.com/diabetes-devices-market.html

New Opportunities and Challenges

Emerging markets offer substantial opportunities because diabetes prevalence is increasing while healthcare systems are expanding access to chronic disease management. Rising healthcare awareness and greater availability of digital technologies can support adoption across Asia Pacific, Latin America, and the Middle East & Africa.

However, affordability remains a major challenge. Advanced CGM systems, insulin pumps, and automated technologies can carry higher costs than conventional monitoring solutions. Unequal healthcare access, reimbursement limitations, patient training requirements, and differences in healthcare infrastructure may also restrict adoption.

Manufacturers that combine affordability, usability, connectivity, and clinical value may find significant opportunities in price-sensitive markets.

Market Trends & Innovations

Innovation is increasingly focused on creating integrated diabetes-management ecosystems rather than standalone devices. Smart insulin pens can combine dosing information with digital applications, while CGM systems can provide continuous glucose readings through compatible smartphones.

Recent industry developments highlight this direction. In February 2025, DexCom launched Dexcom ONE+ in Spain, Belgium, and Poland, offering a customizable CGM solution integrating a wearable sensor, transmitter, and smartphone-compatible application.

In January 2024, Medtronic announced CE Mark approval for its MiniMed 780G system with Simplera Sync, featuring a smaller sensor and simplified insertion process.

These developments illustrate the industry's focus on improving convenience, connectivity, and patient experience.

Future Outlook

The diabetes devices market is expected to maintain strong growth through 2035 as diabetes prevalence increases and healthcare providers place greater emphasis on preventive, personalized, and remote disease management.

CGM and insulin delivery technologies are likely to remain central to market expansion, while artificial pancreas systems, connected applications, and data-driven treatment platforms could open additional growth avenues.

North America currently represents a leading regional market, supported by advanced healthcare infrastructure, high technology adoption, established reimbursement systems, and strong investment in diabetes care. Meanwhile, Asia Pacific presents significant long-term opportunity because of its large population, expanding healthcare infrastructure, and increasing diabetes burden.

Market Segmentation

The diabetes devices market can be segmented as follows:

By Product Type:

·      Glucose Monitoring Devices

·      Self-Monitoring Devices

·      Blood Glucose Meters

·      Testing Strips

·      Lancets

·      Continuous Glucose Monitoring Devices

·      Sensors

·      Transmitters

·      Receivers

·      Insulin Delivery Devices

·      Insulin Syringes

·      Insulin Pens

·      Insulin Pumps

·      Insulin Jet Injectors

·      Diabetes Monitoring Software

·      Artificial Pancreas Systems

By End User:

Hospitals, specialty clinics, diagnostic centers, homecare, and other users including research institutes.

By Region:

North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

👉 To buy this comprehensive market research report, click here to inquire@ https://www.transparencymarketresearch.com/checkout.php?rep_id=14<ype=S

Important FAQs with Answers

What was the global diabetes devices market size in 2024?

The market was valued at approximately US$32.4 billion in 2024.

What is the projected market size by 2035?

The market is projected to reach approximately US$70.6 billion by 2035.

What is the expected CAGR?

The diabetes devices market is projected to grow at a 7.4% CAGR from 2025 to 2035.

Which product segment is prominent?

Insulin delivery devices are a major product category, supported by demand for convenient and precise insulin administration.

What is driving market growth?

Key factors include rising diabetes prevalence, demand for home healthcare, technological innovation, digital health integration, and growing adoption of personalized diabetes management.

More Trending Reports by Transparency Market Research –

High Fluoride Dental Products Market: https://www.transparencymarketresearch.com/high-fluoride-dental-products-market.html

Spine Surgery Products Market: https://www.transparencymarketresearch.com/spine-surgery-products-market.html

Ostomy Dressing Market: https://www.transparencymarketresearch.com/ostomy-dressing-market.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Media Contact: 

Abhishek Budholiya

Transparency Market Research Inc.

State Tower, 90 State Street, Suite 700,

Albany NY - 12207, United States

Tel: +1-518-618-1030

USA – Canada Toll Free: 866-552-3453

Website: https://www.transparencymarketresearch.com 

Sales Inquiries: sales@transparencymarketresearch.com

Media Inquiries: media@transparencymarketresearch.com